Innovation
3 patent families (1 granted) — focus: Human necessities; filing pace dormant. Cited 54 times.
Investor mix
2 investors on record; lead investors include AIG, Galen Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 50% |
| Other / undisclosed | 1 | 50% |